BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,879 | -29.7% | 147,383 | +85.2% | 0.00% | – |
| Q2 2023 | $530,136 | +28310.3% | 79,600 | -20.4% | 0.00% | -100.0% |
| Q1 2023 | $1,866 | -99.9% | 100,000 | -47.0% | 0.00% | -50.0% |
| Q2 2022 | $2,489,000 | +514.6% | 188,548 | +872.6% | 0.00% | – |
| Q1 2022 | $405,000 | +3.6% | 19,385 | +0.7% | 0.00% | – |
| Q4 2021 | $391,000 | -37.9% | 19,250 | +31.9% | 0.00% | – |
| Q1 2021 | $630,000 | -77.7% | 14,597 | -76.1% | 0.00% | -100.0% |
| Q4 2020 | $2,825,000 | -21.6% | 61,145 | -26.4% | 0.00% | -50.0% |
| Q3 2020 | $3,604,000 | +105.0% | 83,120 | +150.7% | 0.00% | +100.0% |
| Q2 2020 | $1,758,000 | +1284.3% | 33,161 | +157.7% | 0.00% | – |
| Q1 2019 | $127,000 | -69.8% | 12,869 | -71.9% | 0.00% | -100.0% |
| Q2 2018 | $421,000 | +33.2% | 45,796 | +48.3% | 0.00% | – |
| Q1 2018 | $316,000 | – | 30,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |